论文信息 - 402MO Final results of the CARACAS study: Randomized phase II trial of avelumab alone or with cetuximab for unresectable, locally advanced or metastatic squamous cell anal carcinoma progressed to at least one line of treatment - 字舞流文

402MO Final results of the CARACAS study: Randomized phase II trial of avelumab alone or with cetuximab for unresectable, locally advanced or metastatic squamous cell anal carcinoma progressed to at least one line of treatment

V. Zagonel | M. Zampino | V. Formica | E. Cortesi | M. Scartozzi | S. Lonardi | F. Pietrantonio | F. Bergamo | V. Conca | M. Messina | M. Prisciandaro | M. Casagrande | M. Ronzoni | M. Antista | L. Frassineti | R. Intini | A. Prete | D. Corsi | D. B. Paola | V. Vettore